Cost — What You Actually Pay in Each Country

---

Cost is where India wins unambiguously. Knee replacement at Thailand's best hospitals — Bumrungrad International, Samitivej, Bangkok Hospital — runs USD 9,700 to 15,200 per knee.

India's JCI-accredited hospitals — Medanta, Apollo, Fortis FMRI — charge USD 4,000 to 7,000 for the same surgery with the same implants. The gap is USD 5,700 to 8,200 per knee.

For bilateral replacement, that gap reaches USD 11,000 to 16,000 for the total procedure.

Flights are typically cheaper to Bangkok from Southeast Asia and Australia. But Delhi's connections from the UK, Africa, and the Gulf are better and often cheaper.

The accommodation cost gap is smaller — serviced apartments near Bangkok hospitals run comparable rates to Gurgaon. The overall total trip cost difference comes to approximately USD 6,000 to 10,000 in India's favour for a single knee replacement.

Item	India	Thailand
TKR single — JCI hospital	$4,000 – $7,000	$9,700 – $15,200
Robotic TKR (MAKO)	$6,000 – $10,000	$12,000 – $25,000
Bilateral TKR	$7,500 – $13,000	$18,000 – $28,000+
Return flights from London	£350 – £700	£500 – £900
Accommodation 25 nights	$875 – $1,750	$1,200 – $2,500
Total trip — single TKR	$5,500 – $10,000	$12,000 – $19,000

Sources: GAF Healthcare hospital tariff data 2026 · Bookimed Thailand price data 2026 · Thailand TKR range from Bumrungrad and top-5 Bangkok hospitals. All costs include surgery, standard implant, hospital stay, surgeon fee, anaesthesia.

Surgical Quality and Volume — The Factor Most Patients Miss

---

Hospital brand and accreditation get most of the attention when patients compare destinations. Surgeon volume gets far less — and it should get far more.

The published evidence on knee replacement outcomes is consistent across decades: the most reliable single predictor of a good outcome is how many knee replacements the surgeon has performed. Not the technology.

Not the hospital brand. The surgeon's volume.

India's highest-volume knee surgeons perform 300 to 500 procedures per year. Some individual surgeons at Medanta and Fortis FMRI have personal career totals exceeding 10,000 and 40,000 joint replacements respectively.

This volume is a function of India's 1.4 billion population combined with decades of concentrated specialist practice — and it is genuinely unusual at a global level, not just in comparison with Thailand.

Thailand's surgeons are well trained — many with fellowships from the USA, UK, and Germany — and produce good outcomes at major centres like Bumrungrad. But they operate in a much smaller healthcare market.

Thai surgeons at the highest-volume orthopaedic hospitals typically perform 80 to 150 joint replacements per year. Research published across orthopaedic journals consistently shows that surgeons performing below 150 procedures per year have measurably higher rates of implant misalignment, complications, and early revision compared to surgeons performing 300 or more.

This is not a criticism of Thai surgeons — it reflects market size, not skill. A surgeon who performs every case they can in Bangkok's private sector is simply limited by the number of patients that city generates.

India's population, combined with the concentration of specialist surgeons in Gurgaon's major hospitals, produces surgical volume that is exceptional by any international benchmark.

Accreditation and Implant Quality — How They Compare

---

Both countries have JCI-accredited hospitals and this is a legitimate comparison point. Bumrungrad in Bangkok holds JCI accreditation.

Apollo Delhi, Medanta, and Fortis FMRI in Gurgaon hold JCI accreditation. The underlying clinical standard that JCI certification represents is the same — external surveyors from the Joint Commission International verify compliance with the same criteria in both countries.

The difference is in depth of accreditation across each country's hospital landscape. India has more JCI-accredited hospitals than Thailand — particularly in the orthopaedic specialty — providing patients with more choice at the accredited level.

Thailand's JCI-accredited orthopaedic programmes are concentrated at Bumrungrad and a small number of Bangkok hospitals. India's accredited orthopaedic programmes span Apollo, Medanta, Fortis FMRI, Max Saket, Kokilaben, Manipal Bangalore, and more across multiple cities.

On implant quality, both countries use the same international brands. Stryker, Zimmer Biomet, and DePuy implants are available at leading hospitals in both India and Thailand.

Patients who specify an international brand implant in either country receive the same product from the same manufacturers. This is an area of genuine equivalence — there is no difference in the implant itself based on destination.

Factor	India	Thailand
JCI accreditation	✅ Multiple hospitals, multiple cities	✅ Bumrungrad + select Bangkok hospitals
Surgeon annual volume	300–500+ (highest globally)	80–150 (good for SE Asia)
Implant brands	Stryker · Zimmer · DePuy available	Stryker · Zimmer · DePuy available
English-language care	✅ Strong across all major hospitals	✅ Excellent at international hospitals
TKR cost per knee	$4,000 – $7,000	$9,700 – $15,200
MAKO robotic TKR	✅ Multiple hospitals	✅ Bumrungrad + KDMS
Bilateral same-session TKR	✅ Strong — world record volume	Available · lower volume
Hospital environment	Clinical · professional · functional	✅ Resort-style · notable service
From Africa / Gulf	✅ Better connected · shorter flight	Longer · more expensive flights
From SE Asia / Australia	Available · longer flight	✅ Shorter · more natural route

Robotic Surgery and Bilateral Replacement

---

Both countries offer MAKO robotic knee replacement. Bumrungrad in Bangkok uses MAKO.

India has MAKO at Apollo Delhi, Medanta Gurgaon, Fortis FMRI Gurgaon, Max Saket, Kokilaben Mumbai, Manipal Bangalore, and other centres. The technology is equivalent.

The cost in India — USD 6,000 to 10,000 for robotic TKR — is significantly less than Bumrungrad's USD 12,000 to 25,000 range for robotic procedures.

Fortis FMRI Gurgaon is additionally the only hospital in the Delhi NCR region — and one of very few globally — offering both MAKO and NAVIO robotic systems for knee replacement. NAVIO is imageless — it requires no pre-operative CT scan, which is relevant for international patients who cannot arrange imaging before travel.

Thailand does not have an equivalent dual-system robotic programme at any single hospital.

For bilateral knee replacement — both knees in one operation — India holds a clear advantage. Medanta in Gurgaon holds a world record for total knee replacement volume and has one of the most active bilateral programmes globally.

Its surgeons have performed more simultaneous bilateral procedures than any Thai hospital by a substantial margin. For patients who specifically need bilateral surgery, this volume difference is clinically meaningful — the risk management, anaesthetic protocols, and post-operative physio planning for bilateral surgery are refined through repetition in ways that lower-volume programmes cannot fully replicate.

Recovery Environment — Where Thailand Genuinely Wins

---

Thailand's strongest argument for knee replacement is not clinical — it is environmental. Bumrungrad is widely described as one of the most comfortable private hospital experiences in the world.

The international wards feel closer to a hotel than a hospital. The service culture is Thai — extraordinarily attentive, deferential, and consistent in a way that is culturally embedded rather than trained.

Bangkok as a recovery city has genuine appeal. The food variety is exceptional.

Getting around on a good day feels manageable once you are mobile enough to use taxis. The city has established itself as a long-stay destination for the kind of international patient who wants their recovery period to feel like a well-organised trip rather than a purely medical visit.

For patients who are travelling with a companion and want that companion to have a genuinely enjoyable three weeks while the patient is in physiotherapy, Bangkok is a more exciting city to be in than Gurgaon.

India's hospitals are not uncomfortable — Medanta, Apollo, and Fortis FMRI are modern, well-equipped, and professionally run. But Gurgaon is not Bangkok.

The city environment is more functional than pleasurable. The hospital wards at India's biggest joint replacement centres are busy — these are high-volume clinical environments, not resort-style patient hotels.

The trade-off for getting the world's highest-volume surgeons is that you are in a large, busy hospital rather than a boutique medical experience.

This is a real consideration that matters to some patients and is irrelevant to others. Patients who are primarily focused on getting the best clinical outcome at the lowest cost will not care about the resort comparison.

Patients for whom the experience of being abroad and recovering in a pleasant environment is a significant part of the decision may reasonably value Thailand's edge here.

Travel and Logistics — Who Can Reach Each Country

---

Flight routing is a legitimate factor in choosing between India and Thailand. For patients from Southeast Asia, Australia, and East Asia — Malaysia, Indonesia, Singapore, Hong Kong, Japan — Bangkok is a more natural and often cheaper hub.

Flights from Kuala Lumpur, Jakarta, or Sydney to Bangkok are shorter and more frequent than equivalent routes to Delhi.

For patients from the UK, Europe, Africa, the Gulf, Central Asia, and South Asia — the nationalities that make up the largest share of India's medical tourist inflow — Delhi is either better connected or equivalent to Bangkok. Emirates, British Airways, and IndiGo connect London and Delhi multiple times daily.

Kenya Airways flies Nairobi to Mumbai direct. Iraqi, Kuwaiti, and Omani patients reach Delhi in three to four hours via their hub airports.

For these patients, the routing comparison does not favour Thailand.

Patient origin	Better connected to India?	Better connected to Thailand?
UK / Europe	✅ Yes — more flights, similar time	Longer, fewer direct options
Nigeria / East Africa	✅ Yes — Ethiopian/Emirates hubs	Significantly longer routing
GCC (UAE / Kuwait / Oman)	✅ Yes — 3–4 hrs direct to Delhi	7–8 hrs via connections
Bangladesh / Sri Lanka	✅ Yes — very close, cheap flights	Longer flight, higher cost
Australia / New Zealand	Similar — 9–12 hrs via hub	✅ Slightly better — 9–10 hrs
Malaysia / Singapore	Available · 5–6 hrs	✅ Yes — 1–2 hrs, many options
USA / Canada	Similar — 14–16 hrs via hub	Similar — 16–20 hrs via hub

The Verdict — Who Should Choose Which Country

---

There is no universal right answer. There is a right answer for your specific situation, which depends on where you are coming from, what surgery you need, how much the cost difference matters, and what your priorities are beyond the clinical outcome.

Choose India if:

Cost is a meaningful factor. You are saving USD 6,000 to 10,000 per procedure — that is real money that goes back into your life.

You need bilateral replacement. India's bilateral volume and the Medanta programme specifically make this comparison very one-sided.

You are coming from the UK, Europe, Africa, the Gulf, or South Asia. The flight routing favours India for all of these patient groups.

You want the highest-volume surgical programme available — surgeon volume for knee replacement is meaningfully higher in India's top centres than anywhere in Thailand. Your surgery has any complexity — partial replacement, revision, or robotic TKR where you want to compare costs between MAKO programmes.

Choose Thailand if:

You are from Southeast Asia or Australia and Bangkok is genuinely a more natural destination — the flight is shorter and cheaper, and the connection is more direct. The hospital environment and service culture matters significantly to you and your companion — Thailand's premium hospitals are genuinely exceptional in this regard.

The cost difference between USD 5,500 and USD 12,000 for a total trip is not meaningful relative to your overall budget. You have a specific preference for a surgeon at Bumrungrad or another Thai hospital and that preference is based on a genuine reason, not just marketing familiarity.

"I spent three months researching Thailand and India. I had seen Bumrungrad's website and assumed it was the obvious choice. Then I looked at the surgeon volume numbers and the bilateral cost difference. I came to Medanta in Gurgaon for both knees. The hospital is not as photogenic as Bumrungrad. The outcome is. Both knees at four months post-op feel better than I was told to expect from either country. I saved USD 14,000. Gurgaon is not Bangkok. I can live with that."